A study reveals that specific diabetes drugs, like dipeptidyl peptidase-4 inhibitors, may lower Alzheimer’s risk by reducing brain amyloid levels and slowing cognitive decline.
A study reveals that specific diabetes drugs, like dipeptidyl peptidase-4 inhibitors, may lower Alzheimer’s risk by reducing brain amyloid levels and slowing cognitive decline.
